Plexus Corp. (NASDAQ:PLXS - Get Free Report) COO Oliver Mihm sold 2,102 shares of the stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $130.43, for a total transaction of $274,163.86. Following the completion of the sale, the chief operating officer owned 21,155 shares in the company, valued at $2,759,246.65. This represents a 9.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Plexus Price Performance
Shares of PLXS stock traded down $0.23 during trading hours on Tuesday, hitting $130.98. The company's stock had a trading volume of 106,169 shares, compared to its average volume of 180,560. The business has a fifty day moving average of $132.56 and a 200-day moving average of $130.23. The stock has a market cap of $3.53 billion, a price-to-earnings ratio of 22.31 and a beta of 0.80. Plexus Corp. has a twelve month low of $103.43 and a twelve month high of $172.89. The company has a current ratio of 1.58, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06.
Plexus (NASDAQ:PLXS - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, beating the consensus estimate of $1.71 by $0.19. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The company's quarterly revenue was up 6.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.45 earnings per share. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. As a group, equities research analysts anticipate that Plexus Corp. will post 5.9 EPS for the current year.
Hedge Funds Weigh In On Plexus
Large investors have recently bought and sold shares of the stock. GAMMA Investing LLC increased its position in shares of Plexus by 49.6% in the first quarter. GAMMA Investing LLC now owns 1,333 shares of the technology company's stock worth $171,000 after acquiring an additional 442 shares in the last quarter. SG Americas Securities LLC acquired a new stake in shares of Plexus in the first quarter worth $917,000. Ritholtz Wealth Management acquired a new stake in shares of Plexus in the first quarter worth $285,000. Deutsche Bank AG increased its position in shares of Plexus by 22.8% in the first quarter. Deutsche Bank AG now owns 47,997 shares of the technology company's stock worth $6,150,000 after acquiring an additional 8,921 shares in the last quarter. Finally, Meeder Asset Management Inc. acquired a new stake in shares of Plexus in the first quarter worth $121,000. Hedge funds and other institutional investors own 94.45% of the company's stock.
Analyst Ratings Changes
Several brokerages recently issued reports on PLXS. Needham & Company LLC reduced their price objective on shares of Plexus from $162.00 to $158.00 and set a "buy" rating on the stock in a research note on Thursday, July 24th. Benchmark reissued a "buy" rating and set a $160.00 price objective on shares of Plexus in a research note on Wednesday, June 4th. Wall Street Zen downgraded shares of Plexus from a "strong-buy" rating to a "buy" rating in a research note on Saturday. Sidoti raised shares of Plexus from a "neutral" rating to a "buy" rating and upped their price objective for the company from $135.00 to $150.00 in a research note on Friday, July 25th. Finally, Stifel Nicolaus set a $140.00 price objective on shares of Plexus in a research note on Thursday, July 24th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $152.00.
Check Out Our Latest Analysis on Plexus
Plexus Company Profile
(
Get Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.